Morepen Laboratories Ltd. Share Price & Stock Analysis

Morepen Laboratories Ltd. (BSE: 500288) is a Gurugram, Haryana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹5,206 Cr, it ranks #822 by market cap among the 6,197 Indian listed companies on FinBizNet, and #23 of 86 in Medicinal Chemicals and Botanical Products. At ₹99.64 (as of 16 Nov 2026), the share price is 33.9% below its 52-week high of ₹150.70 and 195.8% above its 52-week low of ₹33.68. The share price is up 112.1% over one year and up 23.2% over three months.

Key Metrics

Current Price₹99.64
Market Cap₹5,206 Cr
BSE Code500288
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio55.1
Return on Equity7.80%
Return on Assets3.00%
52-Week Range₹33.68 – ₹150.70
1-Year Price Change+112.1%
3-Month Price Change+23.2%
Beta (1Y)0.93
Dividend Yield0.21%
HeadquartersGurugram, Haryana
Websitewww.morepen.com

Latest Quarterly Results — Q2 FY27

Revenue₹747 Cr
Net Profit₹89 Cr
Net Margin11.9%
EPS (Basic)₹1.62
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Morepen Laboratories Ltd. Quarterly Revenue and Profit Trend

Morepen Laboratories Ltd. reported revenue of ₹747 Cr in Q2 FY27, up 81.4% from ₹412 Cr in Q2 FY26 and up 30.9% from ₹570 Cr in Q1 FY27. It posted a net profit of ₹89 Cr for the quarter, against a net profit of ₹41 Cr in Q2 FY26 (up 117.5%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹412 Cr (Q2 FY26) to ₹747 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹747 Cr₹89 Cr11.9%
Q1 FY27₹570 Cr₹56 Cr9.9%
Q4 FY26₹485 Cr₹16 Cr3.2%
Q3 FY26₹484 Cr₹28 Cr5.7%
Q2 FY26₹412 Cr₹41 Cr9.9%
Q1 FY26₹425 Cr₹11 Cr2.5%
Q4 FY25₹466 Cr₹20 Cr4.4%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 35.65% of Morepen Laboratories Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 100.0% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Morepen Laboratories Ltd.

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, di

Products and Services

1. Pharmaceutical Business-This segment manufactures and sells active pharmaceutical ingredients (APIs), formulations, and home health products.

Business Segments

1. Pharmaceutical Business-100%

Morepen Laboratories Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Morepen Laboratories Ltd.₹5,206 Cr55.17.80%₹747 Cr+112.1%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Morepen Laboratories Ltd.?

Morepen Laboratories Ltd. is trading at ₹99.64, with a market capitalisation of ₹5,206 Cr.

Which sector does Morepen Laboratories Ltd. belong to?

Morepen Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Morepen Laboratories Ltd.?

Morepen Laboratories Ltd. has a P/E of 55.1 and a return on equity of 7.80%.

What is the stock symbol of Morepen Laboratories Ltd.?

Morepen Laboratories Ltd. is listed on the BSE under the scrip code 500288.

How has Morepen Laboratories Ltd.'s share price moved over the past year?

Morepen Laboratories Ltd.'s share price is up 112.1% over one year and up 23.2% over three months. Its 52-week range is ₹33.68 to ₹150.70.

What were Morepen Laboratories Ltd.'s latest quarterly results?

In Q2 FY27, Morepen Laboratories Ltd. reported revenue of ₹747 Cr and net profit of ₹89 Cr, with basic EPS of ₹1.62 (consolidated, parsed from the company's exchange filing).

How have Morepen Laboratories Ltd.'s revenue and profit changed over the past year?

Morepen Laboratories Ltd. reported revenue of ₹747 Cr in Q2 FY27, up 81.4% from ₹412 Cr in Q2 FY26 and up 30.9% from ₹570 Cr in Q1 FY27.

What is the promoter holding in Morepen Laboratories Ltd.?

Promoters held 35.65% of Morepen Laboratories Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.